YDES — YD Bio Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual cashflow statement for YD Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | — | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | |
| Standards: | USG | — | USG |
| Status: | Final | fx Preliminary | Final |
| Net Income/Starting Line | 0 | — | -1.41 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | — | — | -0.603 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | — | — | 0.073 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accrued Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Change in Taxes Payable | |||
| Cash from Operating Activities | 0 | — | -1.84 |
| Capital Expenditures | — | — | -2.91 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | — | — | 0.01 |
| Change in Net Investments | |||
| Cash from Investing Activities | — | — | -2.9 |
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | — | — | 7.73 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | — | — | 3.05 |